November 30, 2006 (Chicago) -- Magnetic resonance spectroscopic imaging (MRSI) shows no advantages over magnetic resonance imaging (MRI) alone for localization of peripheral zone prostate cancer in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback